UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): June 12, 2014
Universal Biosensors, Inc.
(Exact Name of Issuer as Specified in Charter)
DELAWARE | 000-52607 | 98-0424072 | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
1 Corporate Avenue, Rowville, 3178, Victoria Australia |
Not Applicable | |
(Address of Principal Executive Offices) | (Zip Code) |
+61 3 9213 9000
(Registrants Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
Item 5.07 Submission of Matters to a Vote of Security Holders.
Universal Biosensors, Inc. (the Company) held its annual meeting of stockholders on June 12, 2014. At the meeting, the Companys stockholders (i) re-elected Mr. Denis Hanley to serve as a director of the Company until the 2017 annual meeting of stockholders, or until his successor is duly elected and qualified; (ii) re-elected Mr. Paul Wright to serve as a director of the Company until the 2017 annual meeting of stockholders, or until his successor is duly elected and qualified; (iii) elected the Boards nominee (Chris Smith) to serve as director of the Company until the 2016 annual meeting of stockholders, or until his successor is duly elected and qualified; (iv) approved the named senior executive compensation; and (v) authorized and approved the grant of 60,000 zero exercise price employee options to acquire shares of common stock (ZEPOs) and 2,040 restricted shares of common stock to the Companys Chief Executive Officer and director, Paul Wright.
Proposal No. |
Proposal |
Votes For | Votes Against |
Abstentions | ||||||||||
Proposal 1(a) | Re-election of Mr. Denis Hanley | 60,717,849 | 31,134,014 | 30,000 | ||||||||||
Proposal 1(b) | Re-election of Mr. Paul Wright | 71,302,851 | 20,549,012 | 30,000 | ||||||||||
Proposal 1(c) | Re-election of Mr. Chris Smith | 70,886,574 | 20,857,992 | 407,297 | ||||||||||
Proposal 2 | Approval of named Senior Executive Remuneration | 70,522,153 | 21,302,670 | 57,040 | ||||||||||
Proposal 3 | Grant of Securities to Mr. Paul Wright | 70,614,184 | 21,203,559 | 64,120 |
* | Note: Under Delaware law, abstentions have the effect of a negative vote with respect to Proposal 2 and Proposal 3. |
For each of the matters described above, the Company received no voting instructions with respect to 10,388,816 million shares held by institutional investors holding those shares.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
UNIVERSAL BIOSENSORS, INC. | ||||||
Date: June 17, 2014 | By: | /s/ Paul Wright | ||||
Name: | Paul Wright | |||||
Title: | Chief Executive Officer |